Gallstone disease occurs more frequently in subjects with the metabolic syndrome and type 2 diabetes. Findings in a mouse model suggest that the forkhead transcription factor FoxO1 lies behind this association (pages 778–782).
References
Ruhl, C.E. & Everhart, J.E. Hepatology 31, 299–303 (2000).
Biddinger, S.B. et al. Nat. Med. 14, 778–782 (2008).
Russell, D.W. Annu. Rev. Biochem. 72, 137–174 (2003).
Smit, J.J. et al. Cell 75, 451–462 (1993).
Berge, K.E. et al. Science 290, 1771–1775 (2000).
Biddinger, S.B. et al. Cell Metab. 7, 125–134 (2008).
Twisk, J. et al. Hepatology 21, 501–510 (1995).
Hofmann, A.F. & Hagey, L.R. Cell Mol. Life Sci. doi:10.1007/s00018-008-7568-6 (17 May 2008).
Apstein, M.D. & Carey, M.C. Eur. J. Clin. Invest. 26, 343–352 (1996).
Buch, S. et al. Nat. Genet. 39, 995–999 (2007).
Jiang, Z.Y. et al. J. Lipid Res. 49, 464–472 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuipers, F., Groen, A. Chipping away at gallstones. Nat Med 14, 715–716 (2008). https://doi.org/10.1038/nm0708-715
Issue Date:
DOI: https://doi.org/10.1038/nm0708-715
- Springer Nature America, Inc.
This article is cited by
-
Structure based classification for bile salt export pump (BSEP) inhibitors using comparative structural modeling of human BSEP
Journal of Computer-Aided Molecular Design (2017)